Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Hunninghake

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
The American Journal of Cardiology|March 12, 1999
Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot studyD A Egan, R Garg, T J Wilt, et al.
The American Journal of Cardiology|January 1, 1997
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/dayM H Davidson, E A Stein, C A Dujovne, et al.
Clinical Cardiology|February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study GroupL Ose, M H Davidson, E A Stein, et al.
The Journal of Nutrition|October 6, 1997
Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysisB H Olson, S M Anderson, M P Becker, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 24, 2001
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemiaM H Davidson, E A Stein, D B Hunninghake, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
The American Journal of Cardiology|March 12, 1999
Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot studyD A Egan, R Garg, T J Wilt, et al.
The American Journal of Cardiology|January 1, 1997
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/dayM H Davidson, E A Stein, C A Dujovne, et al.
Clinical Cardiology|February 19, 2000
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study GroupL Ose, M H Davidson, E A Stein, et al.
The Journal of Nutrition|October 6, 1997
Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysisB H Olson, S M Anderson, M P Becker, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 24, 2001
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemiaM H Davidson, E A Stein, D B Hunninghake, et al.
Pageof 12